FARMINGDALE, N.Y., Aug. 1, 2011 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, has entered into a new three-year exclusive distribution agreement with Osteotrauma Ltda., based in Concepcion, Chile. Osteotrauma will sell and distribute the SonaStar® Ultrasonic Surgical Aspirator and the BoneScalpel™ Ultrasonic Bone Cutter throughout Chile. The agreement includes annual minimum purchase requirements.
Osteotrauma has earned a reputation for introducing high tech, state-of-the-art medical devices to the Chilean market and is respected for their commitment to excellence in customer service. Osteotrauma supplies a wide range of specialty medical products to the Chilean market with a focus on neurosurgery and spine surgery.
The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt™ bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.
The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument while minimizing the peril associated with rotary sharps.
"Misonix is pleased to add Osteotrauma to our sales family as we put the finishing touches on our Latin American distribution network. Their reputation as a quality distributor of medical equipment and devices in Chile is well established," said Michael A. McManus, Jr.